Dutasteride vs. Finasteride for Hair Loss: DHT Potency, Half-Life & Safety Compared

Key Takeaways

Finasteride 1mg is licensed first-line therapy (~70% DHT reduction, ~80% stabilization at 1 year, rapid 6–8 hour half-life clearance).
Dutasteride 0.5mg blocks both Type I and Type II 5-alpha reductase (>90% DHT reduction) and produces higher average hair counts, prescribed off-label when finasteride plateaus.
Both carry similar low rates of reversible sexual side effects and updated regulatory vigilance for rare mood changes (~1 in 1,000) — stop immediately and consult a doctor if low mood occurs.

Both finasteride and dutasteride treat male androgenetic alopecia at its hormonal root by inhibiting 5-alpha reductase, the enzyme that converts testosterone into follicle-shrinking dihydrotestosterone (DHT) (1,2). Understanding their potency and clearance differences helps you and your clinician pick the right starting point.

Clinical comparison: Finasteride 1mg vs. Dutasteride 0.5mg

Clinical Parameter	Finasteride 1mg Daily	Dutasteride 0.5mg Daily
5-Alpha Reductase Blocked	Type II	Type I & Type II
Serum DHT Reduction	~70%	~90%+
Elimination Half-Life	6–8 hours (clears in days)	~5 weeks (persists for months)
Regulatory Status (Hair Loss)	Licensed first-line since 1997	Off-label in the U.S. (licensed in Japan & South Korea)
Time to Visible Results	3–6+ months	3–6+ months

Why most men start with finasteride — and when dutasteride makes sense

Because finasteride 1mg stops hair-loss progression in roughly 80% of men at 12 months (2) and clears from the bloodstream within days if you ever experience side effects, clinicians recommend it first — often paired with topical minoxidil for dual-pathway regrowth (7). Dutasteride 0.5mg (or compounded topical formulas) is typically reserved for rapid hair loss or non-responders after 6–12 months on finasteride (1,6).

Important safety note: Neither drug should be handled or taken during pregnancy (male fetal risk), and regulatory updates highlight rare mood shifts (~1 in 1,000); stop treatment immediately and seek medical advice if you notice depression or mood changes (4,8).

References

Almudaimeegh A, et al. Comparison between dutasteride and finasteride in androgenetic alopecia: systematic review. Dermatol Rep. 2024.
Shapiro J, Kaufman KD. Use of Finasteride in Men With Androgenetic Alopecia. J Investig Dermatol Symp Proc. 2003;8(1):20–3.
Chen L, et al. Finasteride Combined with Topical Minoxidil Meta-analysis. Aesthetic Plast Surg. 2020;44(3):962–70.
U.S. Food and Drug Administration. Propecia (finasteride) prescribing information — psychiatric & sexual adverse events. 2026.

Medical Editorial Review: Reviewed by the Amble Clinical Editorial Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.